Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-03-03

Clinical Trial Update: Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update evaluating a standard preterm infant formula for use in hospitalized preterm infants; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Standard Preterm Infant Formula (preterm infant formula)

Snippet

Sponsor: Abbott Nutrition | Conditions: Pre-term Infants | Phase 2, Phase 3 | Status: COMPLETED